Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jan;31(1):87-88.
doi: 10.1111/iju.15334. Epub 2023 Nov 2.

Editorial comment on Prostate-specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate

Affiliations
Editorial

Editorial comment on Prostate-specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate

Takanori Sekito et al. Int J Urol. 2024 Jan.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Kimura S, Katayama H, Ohara E, Aoki H, Shibuya R, Naganuma H, et al. Prostate specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate. Int J Urol. 2023. doi: 10.1111/iju.15315.
    1. Lambert E, Goossens M, Palagonia E, Vollemaere J, Mazzone E, Dell'Oglio P, et al. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer. World J Urol. 2021;39:2621-2626.
    1. Klein C, Marquette T, Capon G, Yacoub M, Alezra E, Bernhard JC, et al. Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression. Int J Clin Oncol. 2022;27:1077-1083.
    1. Tominaga Y, Sadahira T, Mitsui Y, Maruyama Y, Tanimoto R, Wada K, et al. Favorable long-term oncological and urinary outcomes of incidental prostate cancer following holmium laser enucleation of the prostate. Mol Clin Oncol. 2019;10:605-609.

Publication types

Substances

LinkOut - more resources